Latest News

The listing below shows our latest News Items and is updated regularly.  If you wish to post a news item please select the 'Post News' button on the right.  The displayed news feed starts on 1st August 2016.  Older items can be found here.

To 'Post Your News' use the button at the top right.



From the monthly archives: November, 2017

We are pleased to present below all posts archived in 'November, 2017'. If you still can't find what you are looking for, try using the search box.

Cryopreservation of Hematopoietic Stem Cells

HSC-BANKER® from AMSBIO is a new optimised GMP grade cryopreservation medium for the banking of hematopoietic stem cellsisolated from umbilical cord blood, peripheral blood and bone marrow.    

 

Read the rest of entry »

BioHub Birmingham® expands to meet demand for incubator space

The BioHub Birmingham®, which provides flexible laboratory space for pre-revenue life science companies, has announced its expansion to meet the growing demand for laboratory space in the Midlands.

Read the rest of entry »

Isansys travels with NASA to Antarctica

NASA to evaluate the use of Isansys’ physiological monitoring tools to learn how to monitor explorers as they travel into space.  A NASA exploration scientist set off on his mission to Antarctica being monitored by the Patient Status Engine, a physiological data collection platform which provides monitoring of individuals wirelessly and in real-time.

Read the rest of entry »

MSD announces plan to establish UK Discovery Centre in London

MSD, known as Merck and Co., Inc., in the US and Canada, has today announced its commitment to establish a state of the art life sciences discovery research facility in London, focussed on early bioscience discovery and entrepreneurial innovation

Read the rest of entry »

Life sciences investment will bring 800 jobs to Manchester

German-headquartered Qiagen are one of the firms expected to expand into a campus in the city

Read the rest of entry »

Ipsen get £22m investment in Wrexham

Ipsen, a global biotech group, has announced a £22m investment and recruitment drive for scientists for their base in Wrexham.

Read the rest of entry »

Summit Completes Initial 24 Weeks Of Dosing Of Ezutromid In Patients With Dmd In Phaseout Dmd Clinical Trial

Summit Continues to Expect 24-week Data Q1 2018, which Could Provide Potential Proof of Mechanism for Ezutromid

Read the rest of entry »

OBN Celebrates Successful Inaugural BioSeed® Conference Supporting Innovative Life Sciences Companies’ Accessing Seed Funding

BioSeed® has been designed to provide a platform for innovative life science companies to present and meet with sector specific early stage investors.

Read the rest of entry »

Bonesupporttm - Cerament® G’s Potential To Prevent And Manage Biofilm-Related Bobonesupporttm - Cerament® G’s Potential To Prevent And Manage Biofilm-Related Bone Infections Highlighted In New High-Profile Publication Ne Infections Highlighted In New High

An emerging leader in innovative injectable bio-ceramic bone substitute products to treat bone voids caused by trauma, infection, disease or related surgery based on its unique CERAMENT® platform, announces the publication of a paper highlighting the anti-biofilm activity of CERAMENT®

Read the rest of entry »

Pertinax Pharma appoints Nigel Brooksby as Chairman

Former chairman of Sanofi to help drive the commercialization of Pertinax®

Read the rest of entry »

Pages: Previous12NextReturn Top

Search Posts

News Policy

OBN aims to provide sector NEWS that is relevant to our Membership. We filter information from a variety of sources, publish items ourselves and will publish items of News from our Members. Press releases about OBN can be found here.

OBN Noticeboard

This is an impromptu noticeboard to let people know about events, other things that are happening, perhaps lab equipment for sale etc.  Just drop an email to us, team@obn.org.uk, and we will post.